Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.

While the drugs have grown in popularity among doctors and patients, they are generally too expensive for most people to ...

Runners, cyclists and other fitness enthusiasts say weight-loss drugs give them a performance edge, despite potential risks.

No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for bankruptcy. There’s never a dull ...

The Trump administration has now deported at least two children with cancer, both of whom also happen to be U.S. citizens. ( ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

A Maryland man who took Ozempic and then became legally blind is suing the drug's manufacturer, arguing it had an obligation to warn patients that loss of sight could be a possible side effect. Todd ...

Taking the drug made one writer feel so sick she quit and focused on healthy habits instead of her body size. Turns out, 65% ...

The decision came in response to a February lawsuit from a compounding industry group against the FDA's decision that there ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Novo Nordisk faces a suit claiming it failed to warn users of Ozempic of the danger of blindness. The suit is brought by a ...

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...